{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pubic-lice/prescribing-information/malathion/","result":{"pageContext":{"chapter":{"id":"c3bf4214-4db9-5aed-9e8f-f26920bbc30f","slug":"malathion","fullItemName":"Malathion","depth":2,"htmlHeader":"<!-- begin field 6a18e5ca-96e4-4f31-9e13-32b6a2ea5724 --><h2>Malathion</h2><!-- end field 6a18e5ca-96e4-4f31-9e13-32b6a2ea5724 -->","summary":"","htmlStringContent":"<!-- begin item 4de3cf0c-59d4-4b41-a165-0e36f061aeb3 --><!-- begin field afdcb5e2-6a90-4812-8481-a88000ccdce2 --><ul><li><strong>Contraindications and cautions</strong><ul><li>Known hypersensitivity to the product or its components.</li><li>Pregnancy and breastfeeding.</li><li>Not licensed for use in children under 6 months except under medical supervision. There may be variation in the licensing of different medicines containing the same drug.</li><li>Lotion should not be used more than once a week for 3 consecutive weeks.</li><li>Avoid contact with eyes.</li><li>Do not use on broken or secondarily infected skin.</li><li>Exposure to heat (including hair dryers) should be avoided as malathion products are potentially flammable.</li></ul></li><li><strong>Adverse effects</strong><ul><li>Chemical burns, hypersensitivity reactions and skin irritation may occur.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pubic-lice/references/\">BNF 74, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pubic-lice/references/\">Salavastru, 2017</a>]</p><!-- end field afdcb5e2-6a90-4812-8481-a88000ccdce2 --><!-- end item 4de3cf0c-59d4-4b41-a165-0e36f061aeb3 -->","topic":{"id":"d9c800be-d493-5d1c-81c1-7e9ac00d0e91","topicId":"01c7ac76-ef6e-42b7-836c-ff538154f62a","topicName":"Pubic lice","slug":"pubic-lice","lastRevised":"Last revised in February 2018","chapters":[{"id":"e84df283-1ddd-5fec-bb06-50027c460ccb","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b002a6cc-4c38-5629-b392-ddb39ece58b7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"8c0a40c3-6240-572e-91c8-9c9832c437f7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"75c14179-33ce-5f2a-811b-f8d43efb1dff","slug":"changes","fullItemName":"Changes"},{"id":"7251900b-7e07-51b6-9864-ce5feacb2549","slug":"update","fullItemName":"Update"}]},{"id":"9f11ff42-e98f-52ed-ad50-7ccb91b78747","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"48aa5dc5-ebb5-5204-9cce-98fa93e1fffe","slug":"goals","fullItemName":"Goals"},{"id":"7a514fc4-ac3c-5ece-bdb5-72cb57102cab","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6b51f8aa-d337-50c3-84ee-7ddb0ec0a260","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4d7ae4f3-6c68-5774-afc7-f19a2b8d9bab","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ed24dd27-d5d8-5cfe-a3a9-6231ea4cb3c7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"df2f4d4f-6204-559a-8620-c66f9e707fe5","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"48e97107-2ed4-5dbe-8783-e6a4ad841f4f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"0a849f5f-c58d-5123-b67a-2ed2ed5785e2","slug":"cause","fullItemName":"Cause"},{"id":"d0334bc2-4df2-5845-bce2-445965f164f0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"552d4381-4bfc-56d9-af49-28846d287c6f","slug":"complications","fullItemName":"Complications"},{"id":"f13fad18-e14e-5cfa-ae13-286bd9a1c0d7","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"0c522f07-ff65-5f92-b30a-dcfc2729a67c","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d1bedd68-5e95-5663-a152-06c967e39c73","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f057204e-4214-5cf6-9912-7bb860065936","slug":"assessment","fullItemName":"Assessment"},{"id":"b064b8e0-34ee-5def-a173-fac1c1c12b37","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"dae71d97-8464-5ce8-9069-b5dbfdd59c76","fullItemName":"Management","slug":"management","subChapters":[{"id":"5c26dadb-4955-504f-bc48-288de88e0e36","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b421d0c6-16e3-5df9-a4f1-d872420d92a0","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"b612b27c-a557-5c2d-b4e8-3cf05ed304f5","slug":"permethrin","fullItemName":"Permethrin"},{"id":"c3bf4214-4db9-5aed-9e8f-f26920bbc30f","slug":"malathion","fullItemName":"Malathion"}]},{"id":"de2fbc3d-85e6-5885-a5ed-8656ba93c16b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6d9374ee-83e0-59cf-becb-e16b8ccd36be","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"52d45c19-1905-5e75-b344-8f3e9c345e28","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f9ddc530-3fa3-534f-8e36-4aa5e205a451","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a235b485-afab-5962-a532-dc753485e1f1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"8aaf6bed-e5b8-54fc-8d1a-1546cba416fe","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e5533b71-1715-5937-8266-a8fc60feb025","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"27ce50e8-aa96-5e1d-b770-65a8e2b03760","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b421d0c6-16e3-5df9-a4f1-d872420d92a0","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}